Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eutropin Plus (SR-hGH) in Children with Idiopathic Short Stature
NCT02042170Phase 2Completed
- Sponsor
- LG Chem
- Start
- Feb 2014
- Primary completion
- Mar 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of Eutropin Plus in Idiopathic Short Stature (ISS), sponsored by LG Chem. Started Feb 2014; status: completed.
02
Drugs
Eutropin Plus
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT02042170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042170.